SCHEMBL2729397

SCHEMBL2729397

Cc1cc(C2=CC=C(c3ccc(OCC4OC4C)cc3)CC2)ccc1OCC1OC1C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.34
PPARG P37231 2/20 0.32
PPARD Q03181 1/20 0.32
PPARA Q07869 1/20 0.32
ALDH1A1 P00352 2/20 0.32
GLA P06280 1/20 0.32
GRM2 Q14416 1/20 0.31
TP53 P04637 2/20 0.31
MAPT P10636 2/20 0.31
HPGD P15428 2/20 0.31
TSHR P16473 2/20 0.31
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
KMT2A Q03164 1/20 0.31
HIF1A Q16665 1/20 0.31
LMNA P02545 1/20 0.30
MAOA P21397 1/20 0.30
SLC6A2 P23975 1/20 0.30
TLR8 Q9NR97 1/20 0.30
VDR P11473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2729981 0.89 FFAR4 (0.33) FFAR4PPARGPPARDPPARAALDH1A1
SCHEMBL2729965 0.87 PPARD (0.39) FFAR4PPARGPPARDPPARAALDH1A1
SCHEMBL2719342 0.85 ALDH1A1 (0.49) FFAR4PPARGPPARDPPARAALDH1A1
SCHEMBL2729993 0.81 MCHR1 (0.32)
SCHEMBL2729773 0.76 SSTR4 (0.40) ALDH1A1GLASLC6A2
SCHEMBL2729949 0.74
SCHEMBL2731903 0.74 SLC5A2 (0.34) ALDH1A1GLA
SCHEMBL2829748 0.74 TP53 (0.37) FFAR4PPARGALDH1A1GRM2TP53
SCHEMBL2730179 0.74 SLC5A1 (0.32) PPARGALDH1A1GLATP53MAPT
SCHEMBL2720240 0.73 PPARG (0.40) FFAR4PPARGPPARDPPARAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1995245-B1 METHOD FOR PRODUCING EPOXY COMPOUND SUMITOMO CHEMICAL CO (JP) 2012-05-02 EP disclosed
US-20100160555-A1 RESIN COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-24 US disclosed
US-20100144926-A1 EPOXY RESIN COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-10 US disclosed
EP-2133379-A1 EPOXY RESIN COMPOSITION Sumitomo Chemical Company, Limited (JP) 2009-12-16 EP disclosed
EP-2133380-A1 RESIN COMPOSITION Sumitomo Chemical Company, Limited (JP) 2009-12-16 EP disclosed
US-20090054669-A1 Process For Producing Epoxy Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-02-26 US disclosed
US-20090018355-A1 Process for Crystallizing an Epoxy Compound SUMITOMO CHEMICAL COMPANY, LTD. 2009-01-15 US disclosed
EP-1995245-A1 METHOD FOR PRODUCING EPOXY COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-11-26 EP disclosed
EP-1995244-A1 METHOD FOR CRYSTALLIZATION OF EPOXY COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-11-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018355-A1 Process for Crystallizing an Epoxy Compound PTGER1, NR5A1, TCP1 FFAR4 3209/4885PPARG 2038/4885PPARD 4113/4885
US-20090054669-A1 Process For Producing Epoxy Compound RER1, AR, CYP1A1 FFAR4 3437/4885PPARG 2278/4885PPARD 3581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.